AstraZeneca today announced that Marc Dunoyer is to join the company in the
newly created role of Executive Vice President, Global Portfolio & Product
Marc will be responsible for driving business strategy, including business
development, mergers and acquisitions, portfolio and product strategies. His
most critical priorities will be to bolster the core growth platforms and
therapy areas through well executed business development initiatives and
leadership of internal efforts.